Nationwide Fund Advisors Reduces Position in Steris Plc (STE)
Nationwide Fund Advisors lowered its holdings in shares of Steris Plc (NYSE:STE) by 7.3% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 501,388 shares of the medical equipment provider’s stock after selling 39,335 shares during the period. Nationwide Fund Advisors owned approximately 0.59% of Steris Plc worth $40,863,000 at the end of the most recent reporting period.
A number of other large investors have also bought and sold shares of the stock. Private Harbour Investment Management & Counsel LLC boosted its stake in Steris Plc by 0.4% during the second quarter. Private Harbour Investment Management & Counsel LLC now owns 10,424 shares of the medical equipment provider’s stock worth $850,000 after acquiring an additional 40 shares in the last quarter. Van ECK Associates Corp boosted its stake in Steris Plc by 0.4% during the first quarter. Van ECK Associates Corp now owns 10,770 shares of the medical equipment provider’s stock worth $748,000 after acquiring an additional 45 shares in the last quarter. Sawtooth Solutions LLC boosted its stake in Steris Plc by 1.3% during the second quarter. Sawtooth Solutions LLC now owns 4,232 shares of the medical equipment provider’s stock worth $345,000 after acquiring an additional 54 shares in the last quarter. Westside Investment Management Inc. boosted its stake in Steris Plc by 2.7% during the first quarter. Westside Investment Management Inc. now owns 4,800 shares of the medical equipment provider’s stock worth $333,000 after acquiring an additional 125 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan boosted its stake in Steris Plc by 0.5% during the first quarter. Municipal Employees Retirement System of Michigan now owns 39,480 shares of the medical equipment provider’s stock worth $2,742,000 after acquiring an additional 180 shares in the last quarter. 94.67% of the stock is currently owned by institutional investors and hedge funds.
In other news, Director Richard Martin Steeves sold 156,072 shares of the business’s stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $87.13, for a total transaction of $13,598,553.36. Following the transaction, the director now owns 9,362 shares of the company’s stock, valued at approximately $815,711.06. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the business’s stock in a transaction dated Wednesday, August 16th. The shares were sold at an average price of $85.69, for a total transaction of $856,900.00. Following the transaction, the chief executive officer now directly owns 83,270 shares in the company, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. Insiders sold a total of 179,881 shares of company stock worth $15,608,811 in the last three months. 2.55% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: “Nationwide Fund Advisors Reduces Position in Steris Plc (STE)” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/nationwide-fund-advisors-reduces-position-in-steris-plc-ste/1561829.html.
Shares of Steris Plc (NYSE STE) traded up 0.02% during trading on Thursday, hitting $87.11. 94,164 shares of the company were exchanged. The firm’s 50-day moving average price is $85.01 and its 200 day moving average price is $77.70. Steris Plc has a 12 month low of $63.80 and a 12 month high of $88.11. The firm has a market capitalization of $7.42 billion, a PE ratio of 62.31 and a beta of 1.29.
Steris Plc (NYSE:STE) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The firm had revenue of $608.00 million for the quarter, compared to analysts’ expectations of $597.66 million. During the same quarter last year, the company earned $0.79 EPS. The firm’s revenue for the quarter was down 4.8% compared to the same quarter last year. On average, equities research analysts expect that Steris Plc will post $4.06 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Thursday, September 28th. Investors of record on Tuesday, August 29th will be paid a $0.31 dividend. The ex-dividend date of this dividend is Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a yield of 1.42%. This is a boost from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio (DPR) is currently 88.57%.
Several brokerages have issued reports on STE. Wellington Shields cut shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Zacks Investment Research raised shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price for the company in a report on Tuesday, July 11th. BidaskClub cut shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Finally, Raymond James Financial, Inc. lifted their target price on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Steris Plc presently has an average rating of “Buy” and a consensus target price of $86.75.
About Steris Plc
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.